Mackenzie Financial
AQST icon

Mackenzie Financial’s Aquestive Therapeutics AQST Stock Holding History

Mackenzie Financial’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,318
Closed -$24K – 1437
2022
Q3 		$24K Sell
20,318
-41,381
-67% -$46.8K ﹤0.01% 1401
2022
Q2 		$39K Buy
+61,699
New +$82.1K ﹤0.01% 1409

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LI
Latash Investments Anchorage, Alaska $129M AUM 14.69% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Mackenzie Financial's AQST Position: Q4 2022 in Review

Mackenzie Financial sold out of Aquestive Therapeutics (AQST) in Q4 2022, closing a stake of 20,318 shares — an estimated $24K sold.

Mackenzie Financial first reported a position in AQST in Q2 2022 and held it in 2 quarters. The position peaked at $39K in Q2 2022. 37 funds tracked by Wall St. Rank hold AQST as of Q4 2022.

  • Mackenzie Financial reported no remaining Aquestive Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Mackenzie Financial sold 20,318 Aquestive Therapeutics shares in Q4 2022, an estimated $24K.
  • Mackenzie Financial first reported a position in Aquestive Therapeutics in Q2 2022 and held it in 2 quarters.
  • Mackenzie Financial's Aquestive Therapeutics position peaked at $39K in Q2 2022.
  • 37 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q4 2022.

Based on Mackenzie Financial's 13F filing for Q4 2022, filed 14 Feb 2023.